PCDH17 and neoplasm: Furthermore, the tumor transendothelial migration assay also demonstrated that PCDH17 facilitates the extravasation and metastasis of HCT116 cells was abolished in HUVECs treated with siVEGFR2 (P < 0.001; Fig. 5F).